• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACR 适宜性标准®:子宫颈浸润性癌的治疗前评估和随访:2023 年更新。

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update.

机构信息

Brigham & Women's Hospital Dana-Farber Cancer Institute, Boston, Massachusetts.

Research Author, Brigham & Women's Hospital, Boston, Massachusetts.

出版信息

J Am Coll Radiol. 2024 Jun;21(6S):S249-S267. doi: 10.1016/j.jacr.2024.02.026.

DOI:10.1016/j.jacr.2024.02.026
PMID:38823948
Abstract

Cervical cancer is a common gynecological malignancy worldwide. Cervical cancer is staged based on the International Federation of Gynecology and Obstetrics (FIGO) classification system, which was revised in 2018 to incorporate radiologic and pathologic data. Imaging plays an important role in pretreatment assessment including initial staging and treatment response assessment of cervical cancer. Accurate determination of tumor size, local extension, and nodal and distant metastases is important for treatment selection and for prognostication. Although local recurrence can be diagnosed by physical examination, imaging plays a critical role in detection and follow-up of local and distant recurrence and subsequent treatment selection. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

摘要

宫颈癌是全球常见的妇科恶性肿瘤。宫颈癌的分期基于国际妇产科联盟(FIGO)分类系统,该系统于 2018 年进行了修订,纳入了影像学和病理学数据。影像学在治疗前评估中起着重要作用,包括宫颈癌的初始分期和治疗反应评估。准确确定肿瘤大小、局部扩展以及淋巴结和远处转移对于治疗选择和预后具有重要意义。尽管可以通过体格检查诊断局部复发,但影像学在检测和随访局部和远处复发以及随后的治疗选择方面起着关键作用。美国放射学院(ACR)适宜性标准是针对特定临床情况的循证指南,每年由多学科专家小组进行审查。指南的制定和修订过程支持对同行评议期刊的医学文献进行系统分析。既定的方法学原则,如推荐评估、制定和评估分级(Grading of Recommendations Assessment, Development, and Evaluation 或 GRADE),被用于评估证据。RAND/UCLA 适宜性方法用户手册提供了用于确定特定临床情况下影像学和治疗程序适宜性的方法。在缺乏或存在争议的同行评议文献的情况下,专家可能是制定建议的主要证据来源。

相似文献

1
ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update.ACR 适宜性标准®:子宫颈浸润性癌的治疗前评估和随访:2023 年更新。
J Am Coll Radiol. 2024 Jun;21(6S):S249-S267. doi: 10.1016/j.jacr.2024.02.026.
2
ACR Appropriateness Criteria® Imaging of Invasive Breast Cancer.ACR 适宜性标准®浸润性乳腺癌影像学检查。
J Am Coll Radiol. 2024 Jun;21(6S):S168-S202. doi: 10.1016/j.jacr.2024.02.021.
3
ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update.ACR 适宜性标准® 肾癌分期:2022 年更新版。
J Am Coll Radiol. 2023 May;20(5S):S246-S264. doi: 10.1016/j.jacr.2023.02.008.
4
ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update.ACR 适宜性标准®监测乳腺癌新辅助全身治疗的反应:2022 更新版。
J Am Coll Radiol. 2023 May;20(5S):S125-S145. doi: 10.1016/j.jacr.2023.02.016.
5
ACR Appropriateness Criteria® Staging and Follow-Up of Esophageal Cancer.ACR 适宜性标准® 食管癌分期和随访。
J Am Coll Radiol. 2022 Nov;19(11S):S462-S472. doi: 10.1016/j.jacr.2022.09.008.
6
ACR Appropriateness Criteria® Soft Tissue Masses: 2022 Update.ACR 适宜性标准®软组织肿块:2022 年更新版。
J Am Coll Radiol. 2023 May;20(5S):S234-S245. doi: 10.1016/j.jacr.2023.02.009.
7
ACR Appropriateness Criteria® Palpable Breast Masses: 2022 Update.ACR 适宜性标准®可触及乳房肿块:2022 年更新。
J Am Coll Radiol. 2023 May;20(5S):S146-S163. doi: 10.1016/j.jacr.2023.02.013.
8
ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms: 2023 Update.ACR 适宜性标准® 临床疑似附件包块,无急性症状:2023 年更新。
J Am Coll Radiol. 2024 Jun;21(6S):S79-S99. doi: 10.1016/j.jacr.2024.02.017.
9
ACR Appropriateness Criteria® Chronic Shoulder Pain: 2022 Update.ACR 适宜性标准®慢性肩部疼痛:2022 年更新版。
J Am Coll Radiol. 2023 May;20(5S):S49-S69. doi: 10.1016/j.jacr.2023.02.017.
10
ACR Appropriateness Criteria® Malignant or Aggressive Primary Musculoskeletal Tumor-Staging and Surveillance: 2022 Update.ACR 适宜性标准® 恶性或侵袭性原发性肌肉骨骼肿瘤的分期和监测:2022 年更新版。
J Am Coll Radiol. 2022 Nov;19(11S):S374-S389. doi: 10.1016/j.jacr.2022.09.015.

引用本文的文献

1
Tumor Invasion Distance Based on MRI Is a Novel Prognostic Indicator for I-IIIB Cervical Cancer Patients Treated with Radiotherapy.基于MRI的肿瘤浸润深度是接受放疗的I-IIIB期宫颈癌患者的一种新型预后指标。
Curr Oncol. 2025 Jun 16;32(6):355. doi: 10.3390/curroncol32060355.
2
Analysis of prognosis and related influencing factors of different surgical approaches for early cervical cancer.早期宫颈癌不同手术方式的预后及相关影响因素分析
J Cancer Res Clin Oncol. 2025 Mar 1;151(3):97. doi: 10.1007/s00432-025-06139-4.